Table 2.
Distribution of tumor entities for benign, malignant and non-neoplastic soft tissue masses ≤5 cm, ≤3 cm and ≤2 cm located superficial to the fascia
| Benign | Malignant | Non-neoplastic | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Entity | ≤5 cm | ≤3 cm | ≤2 cm | Entity | ≤5 cm | ≤3 cm | ≤2 cm | Entity | ≤5 cm | < 3 cm | ≤2 cm |
| Overall | 97 (57.06%) | 57 (56.43%) | 35 (53.03%) | 40 (23.53%) | 21 (20.79%) | 12 (18.18%) | 33 (19.41%) | 23 (22.77%) | 19 (28.79%) | ||
| Deep benign fibrous histiocytoma | 1 (0.59%) | – | – | Angiosarcoma of soft tissue | 1 (0.59%) | – | – | Ganglion | 20 (11.76%) | 16 (15.84%) | 12 (18.18%) |
| Fibroma | 5 (2.94%) | 3 (2.97%) | 3 (4.55%) | Dermatofibrosarcoma protuberans | 6 (3.53%) | 4 (3.96%) | 3 (4.55%) | Haematoma | 2 (1.18%) | 1 (0.99%) | 1 (1.52%) |
| Fibromatosis | 11 (6.47%) | 9 (8.91%) | 7 (10.61%) | Ewing-Sarcoma | 1 (0.59%) | 1 (0.99%) | 1 (1.52%) | Pseudotumor | 5 (2.94%) | 1 (0.99%) | 1 (1.52%) |
| Haemangioma | 11 (6.47%) | 9 (8.91%) | 6 (9.09%) | Extrapleural solitary fibrous tumor | 1 (0.59%) | 1 (0.99%) | 1 (1.52%) | Others | 6 (3.53%) | 5 (4.95%) | 5 (7.58%) |
| Hamartoma | 1 (0.59%) | 1 (0.99%) | 1 (1.52%) | Fibrosarcoma | 2 (1.18%) | 2 (1.98%) | 1 (1.52%) | ||||
| Hibernoma | 1 (0.59%) | – | – | Haemangioendothelioma | 1 (0.59%) | 1 (0.99%) | 1 (1.52%) | ||||
| Lipoma | 50 (29.41%) | 22 (21.78%) | 10 (15.15%) | Leyomyosarcoma | 4 (2.35%) | 1 (0.99%) | 1 (1.52%) | ||||
| Myxoma | 1 (0.59%) | – | – | Liposarcoma a | 4 (2.35%) | 2 (1.98%) | – | ||||
| Nodular fasciitis | 1 (0.59%) | 1 (0.99%) | 1 (1.52%) | Metastasis | 3 (1.76%) | 1 (0.99%) | 1 (1.52%) | ||||
| Schwannoma | 9 (5.29%) | 9 (8.91%) | 5 (7.58%) | Myofibroblastic tumor | 1 (0.59%) | 1 (0.99%) | – | ||||
| Tenosynovial giant cell tumor | 6 (3.53%) | 3 (2.97%) | 2 (3.03%) | Myxofibrosarcoma | 5 (2.94%) | 1 (0.99%) | 1 (1.52%) | ||||
| Undifferentiated pleomorphic sarcoma | 9 (5.29%) | 4 (3.96%) | 1 (1.52%) | ||||||||
| Sarcoma, not otherwise specified | 2 (1.18%) | 2 (1.98%) | 1 (1.52%) | ||||||||
aof those classified as low-grade liposarcoma/atypical lipomatous tumor: 1 ≤ 5 cm (0.59%), 0 ≤ 3 cm, 0 ≤ 2 cm